| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |